New York State Common Retirement Fund
CCCC icon

New York State Common Retirement Fund’s C4 Therapeutics CCCC Stock Holding History

New York State Common Retirement Fund’s Portfolio CCCC Stock Details CCCC Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q2 		– Sell
-9,100
Closed -$14.6K – 3220
2025
Q1 		$14.6K Hold
9,100
– – ﹤0.01% 3024
2024
Q4 		$32.8K Hold
9,100
– – ﹤0.01% 2959
2024
Q3 		$51.9K Sell
9,100
-14,600
-62% -$87.9K ﹤0.01% 2853
2024
Q2 		$109K Buy
+23,700
New +$141K ﹤0.01% 2707
2023
Q3 		– Sell
-320
Closed -$880 – 3286
2023
Q2 		$880 Sell
320
-7,544
-96% -$24.2K ﹤0.01% 3322
2023
Q1 		$24.7K Sell
7,864
-20,738
-73% -$122K ﹤0.01% 3104
2022
Q4 		$169K Buy
28,602
+25
+0.1% +$207 ﹤0.01% 2796
2022
Q3 		$251K Buy
28,577
+125
+0.4% +$1.3K ﹤0.01% 2666
2022
Q2 		$215K Sell
28,452
-89
-0.3% -$783 ﹤0.01% 2767
2022
Q1 		$692K Buy
28,541
+18
+0.1% +$437 ﹤0.01% 2263
2021
Q4 		$918K Buy
28,523
+3,568
+14% +$141K ﹤0.01% 2139
2021
Q3 		$1.11M Sell
24,955
-4,626
-16% -$198K ﹤0.01% 2066
2021
Q2 		$1.12M Buy
29,581
+20,181
+215% +$723K ﹤0.01% 2174
2021
Q1 		$348K Buy
9,400
+1,600
+21% +$63.6K ﹤0.01% 2626
2020
Q4 		$258K Buy
+7,800
New +$226K ﹤0.01% 2640

Other funds holding CCCC

WA
Wasatch Advisors Salt Lake City, Utah $15.3B AUM 25.06% 1-Year Est. Return
LCM
Lynx1 Capital Management San Juan, Puerto Rico $633M AUM 173.22% 1-Year Est. Return
SCM
Soleus Capital Management Greenwich, Connecticut $2.47B AUM 115.63% 1-Year Est. Return
O
OrbiMed New York $5.05B AUM 125.28% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
BCLSI
Bain Capital Life Sciences Investors Boston, Massachusetts $1.11B AUM 171.34% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

New York State Common Retirement Fund's CCCC Position: Q2 2025 in Review

New York State Common Retirement Fund sold out of C4 Therapeutics (CCCC) in Q2 2025, closing a stake of 9,100 shares — an estimated $14.6K sold.

New York State Common Retirement Fund first reported a position in CCCC in Q4 2020 and held it in 15 quarters. The position peaked at $1.12M in Q2 2021. 102 funds tracked by Wall St. Rank hold CCCC as of Q2 2025.

  • New York State Common Retirement Fund reported no remaining C4 Therapeutics position as of Q2 2025 after selling out during the quarter.
  • New York State Common Retirement Fund sold 9,100 C4 Therapeutics shares in Q2 2025, an estimated $14.6K.
  • New York State Common Retirement Fund first reported a position in C4 Therapeutics in Q4 2020 and held it in 15 quarters.
  • New York State Common Retirement Fund's C4 Therapeutics position peaked at $1.12M in Q2 2021.
  • 102 funds tracked by Wall St. Rank held C4 Therapeutics as of Q2 2025.

Based on New York State Common Retirement Fund's 13F filing for Q2 2025, filed 13 Aug 2025.